As a former policy director at FDA and business development leader at a national biotechnology company, Paul brings unique first-hand experience with the development and application of regulatory programs to counsel clients at all stages of the medical product life cycle. Paul’s practice primarily focuses on representing medical device companies, small and large alike, in efficiently navigating local and national regulatory requirements. *Not admitted in the District of Columbia. Admitted in Maryland only. Practicing under supervision of Firm principals.